A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
for Macular Degeneration
48 locations incl. Gilbert
Sponsor: EyeBiotech Ltd.
Sex: All·Age: 50+
Code: NCT07496567·Phase 2, Phase 3·Recruiting·Listed Mar 2026
Retina Consultants of Southern Colorado
Clinical research site in Colorado Springs, Colorado · 2770 N UNION BLVD, SUITE 140, COLORADO SPRINGS, CO 80909-1183 · (719) 473-9595 · Website
As of July 2026, 8 paid clinical trials are recruiting at Retina Consultants of Southern Colorado in Colorado Springs, Colorado. Active studies at this site cover conditions such as Geographic Atrophy (GA), Macular Degeneration and Age - Related Macular Degeneration (AMD). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Retina Consultants of Southern Colorado (8)
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
for Diabetic Macular Edema
50 locations incl. Bakersfield
Sponsor: EyePoint Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT07449936·Phase 3·Recruiting·Listed Mar 2026
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
for Age-related Macular Degeneration (AMD)
140 locations incl. Chandler
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 50 - 85
Code: NCT06541704·Phase 3·Recruiting·Listed Aug 2024
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for Neovascular Age-related Macular Degeneration
51 locations incl. Mesa
Sponsor: AbbVie
Sex: All·Age: 50+
Code: NCT07007065·Phase 3·Recruiting·Listed Jun 2025
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
for Geographic Atrophy (GA)
49 locations incl. Gilbert
Sponsor: ONL Therapeutics
Sex: All·Age: 55+
Code: NCT06659445·Phase 2·Recruiting·Listed Oct 2024
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
for Geographic Atrophy
54 locations incl. Phoenix
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: All ages
Code: NCT06779773·Recruiting·Listed Jan 2025
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
for Neovascular Age-Related Macular Degeneration (nAMD)
54 locations incl. Scottsdale
Sponsor: 4D Molecular Therapeutics
Sex: All·Age: 50+
Code: NCT07064759·Phase 3·Recruiting·Listed Jul 2025
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
for AMD
65 locations incl. Phoenix
Sponsor: AbbVie
Sex: All·Age: 50 - 89
Code: NCT05407636·Phase 3·Recruiting·Listed Jun 2022
More research sites in Colorado Springs
- UCHealth Memorial Hospital Central (32 trials)
- Rocky Mountain Cancer Centers-Penrose (30 trials)
- Memorial Hospital North (29 trials)
- Penrose-Saint Francis Healthcare (29 trials)
- Saint Francis Cancer Center (28 trials)
- Peak Gastroenterology Associates (22 trials)
- Colorado ENT & Allergy (6 trials)
- Rocky Mountain Cancer Centers, LLP (4 trials)
- Asthma and Allergy Associates, PC (4 trials)
- University of Colorado Colorado Springs (4 trials)
Explore more
Paid clinical trials in Colorado Springs, CO · Colorado clinical trials